3-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)benzoic acid

Catalog No. :
ACPDBZ198
CAS No. :
317355-21-8
Molecular Formula :
C16H21NO4
Molecular Weight :
291.35

IUPAC Name:3-(1-(tert-butoxycarbonyl)pyrrolidin-2-yl)benzoic acid

3-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$144.00Login to see priceIn stockInquiry
100mg98%$255.00Login to see priceIn stockIn stock
250mg98%$432.00Login to see priceIn stockIn stock
1g98%$1162.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)benzoic acid
IUPAC Name3-(1-(tert-butoxycarbonyl)pyrrolidin-2-yl)benzoic acid
Molecular FormulaC16H21NO4
Molecular Weight291.35
SMILESO=C(O)C1=CC=CC(C2N(C(OC(C)(C)C)=O)CCC2)=C1
InChI KeyDZIBTUILRRHUTI-UHFFFAOYSA-N
SynonymN-Boc-3-pyrrolidin-2-yl-benzoic acid;3-[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]benzoic acid;1-Pyrrolidinecarboxylic acid, 2-(3-carboxyphenyl)-, 1-(1,1-dimethylethyl) ester
CAS No.317355-21-8
PubChem CID45073984

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPDBZ198 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPDBZ198 route product structure diagram
    ACPDBZ198317355-21-8 In Stock
Inquiry

2. ACPDBZ198 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTFLI348 route compound structure diagram
    ACTFLI3482241594-16-9 In Stock
  4. Then
  5. ACPDBZ198 route product structure diagram
    ACPDBZ198317355-21-8 In Stock
Inquiry

Comments (0)